Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry.
- DOI
- 10.1002/cncr.70353
- Published
- 2026 Apr 15
- Container
- Cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cncr.70353,
title = {Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry.},
author = {Alonso-Dominguez JM and Castaño-Bonilla T and Gil C and Serrano-Lopez J and Martinez-Sanchez P and Herrera P and Garcia-Boyero R and Rodriguez-Arboli E and Brioso-Infante J and Benavente C and Lavilla-Rubira E and Tormo M and Sayas-Lloris MJ and Lainez-Gonzalez D and Serrano-Lopez J and Amigo ML and Algarra L and Unamunzaga A and Alonso-Alonso JM and Garcia-Garay MC and Callejas-Charavia M and Roldan-Perez A and Cornago-Navascues J and Valero-Nuñez M and Alfonso-Pierola A and Perez-Santaolalla E and Sobas M and Romero-Riquelme M and Lopez M and Galvez K and Rodríguez-Veiga R and Barragan E and Ayala R and Solana-Altabella A and Lloret-Madrid P and Montesinos P},
year = {2026},
journal = {Cancer},
doi = {10.1002/cncr.70353},
url = {https://doi.org/10.1002/cncr.70353}
}RIS
TY - JOUR TI - Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry. AU - Alonso-Dominguez JM AU - Castaño-Bonilla T AU - Gil C AU - Serrano-Lopez J AU - Martinez-Sanchez P AU - Herrera P AU - Garcia-Boyero R AU - Rodriguez-Arboli E AU - Brioso-Infante J AU - Benavente C AU - Lavilla-Rubira E AU - Tormo M AU - Sayas-Lloris MJ AU - Lainez-Gonzalez D AU - Serrano-Lopez J AU - Amigo ML AU - Algarra L AU - Unamunzaga A AU - Alonso-Alonso JM AU - Garcia-Garay MC AU - Callejas-Charavia M AU - Roldan-Perez A AU - Cornago-Navascues J AU - Valero-Nuñez M AU - Alfonso-Pierola A AU - Perez-Santaolalla E AU - Sobas M AU - Romero-Riquelme M AU - Lopez M AU - Galvez K AU - Rodríguez-Veiga R AU - Barragan E AU - Ayala R AU - Solana-Altabella A AU - Lloret-Madrid P AU - Montesinos P PY - 2026 JO - Cancer DO - 10.1002/cncr.70353 UR - https://doi.org/10.1002/cncr.70353 ER -
APA
JM, A., T, C., C, G., J, S., P, M., P, H., R, G., E, R., J, B., C, B., E, L., M, T., MJ, S., D, L., J, S., ML, A., L, A., A, U., JM, A., MC, G., M, C., A, R., J, C., M, V., A, A., E, P., M, S., M, R., M, L., K, G., R, R., E, B., R, A., A, S., P, L., & P, M. (2026). Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry.. Cancer. https://doi.org/10.1002/cncr.70353
Source records
- pubmed · retrieved 2026-09-26T19:06:15.087Z